Study of Radium-223 Dichloride Versus Placebo and Treatment With Exemestane / Everolimus in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer
about
Study of Radium-223 Dichloride Versus Placebo and Treatment With Exemestane / Everolimus in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
Study of Radium-223 Dichloride ...... itive Metastatic Breast Cancer
@en
type
label
Study of Radium-223 Dichloride ...... itive Metastatic Breast Cancer
@en
prefLabel
Study of Radium-223 Dichloride ...... itive Metastatic Breast Cancer
@en
P17
P4844
P131
P1476
A Phase II Randomized, Double- ...... Subjects With Bone Metastases
@en
P17
P3098
NCT02258451
P580
2015-06-04T00:00:00Z
P582
2019-07-31T00:00:00Z